0.0021
-0.0188
(-89.95%)
At close: April 16 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
9,518
9,518
20,382
20,571
15,834
Operating Income
-9,518
-9,518
-20,382
-20,571
-15,834
Net Non Operating Interest Income Expense
348
348
220
4
12
Other Income Expense
538
538
3,825
3,492
-72
Pretax Income
-8,632
-8,632
-16,337
-17,075
-15,894
Net Income Common Stockholders
-8,632
-8,632
-16,337
-17,075
-15,894
Average Dilution Earnings
--
--
-5,761
--
--
Diluted NI Available to Com Stockholders
-8,632
-8,632
-22,098
-17,075
-15,894
Basic EPS
-10.66
--
-21.68
-27.00
-27.00
Diluted EPS
-10.66
--
-29.32
-30.00
-27.00
Basic Average Shares
810.1130
--
753.6150
664.3300
576.1550
Diluted Average Shares
810.1130
--
753.6150
683.2100
576.1550
Total Expenses
9,518
9,518
20,382
20,571
15,834
Net Income from Continuing & Discontinued Operation
-8,632
-8,632
-16,337
-17,075
-15,894
Normalized Income
-8,576
-8,576
-20,162
-20,567
-15,822
Interest Income
348
348
220
4
12
Net Interest Income
348
348
220
4
12
EBIT
-9,518
-9,518
-20,382
-20,571
-15,834
EBITDA
-9,396
-9,396
-19,334
-19,477
-14,657
Reconciled Depreciation
122
122
1,048
1,094
1,177
Net Income from Continuing Operation Net Minority Interest
-8,632
-8,632
-16,337
-17,075
-15,894
Total Unusual Items Excluding Goodwill
-56
-56
3,825
3,492
-72
Total Unusual Items
-56
-56
3,825
3,492
-72
Normalized EBITDA
-9,340
-9,340
-23,159
-22,969
-14,585
12/31/2020 - 7/31/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AKTX Akari Therapeutics, Plc
1.1000
-6.78%
QNNTF Quantum Genomics Société Anonyme
0.1000
0.00%
AXIM AXIM Biotechnologies, Inc.
0.0040
+2.56%
GYX.MU Futura Medical PLC
0.1270
0.00%
ACUT AccuStem Sciences, Inc.
0.6100
+35.28%
EVLO Evelo Biosciences, Inc.
0.0005
0.00%
ADXS Ayala Pharmaceuticals, Inc.
0.0317
+3.77%
AMBS Amarantus BioScience Holdings, Inc.
0.0005
0.00%
ANEB Anebulo Pharmaceuticals, Inc.
1.0400
+9.47%
BTTX Better Therapeutics, Inc.
0.0004
+33.33%